Cartilage differentiation is a complex, incompletely understood process. A culture system developed in our laboratory facilitates the chondrogenic differentiation of postnatal mammalian bone marrow-derived mesenchymal progenitor cells. We hypothesize that this in vitro process recapitulates that which occurs in vivo and that it can be used to define the molecular events that are important in the process of chondrogenesis. The first specific aim is to examine the cell biology of the system; including the number and type of cells that take part in the process, quantification of the proliferation and cell death that occurs and the commitment of cells in the later stages of the process. The second specific aim is to define the temporal sequence for the expression of specific extracellular matrix molecules produced during differentiation, as a means to staging the process. Most studies of skeletogenesis in vitro involve the addition of cytokines as a means to defining their functions. We hypothesize that by identifying the cytokines that are intrinsic to the cells in the culture system, and defining the sequence of their up- or down- regulation, we will be able to more accurately define the functions of the cytokines in chondrocyte differentiation. Therefore, the third specific aim is to define the temporal sequence of endogenous cytokine induction and repression during the process of chondrogenesis. The use of targeted RNA fingerprinting will allow screening and identification of specific factors which are within cytokine families known to be involved in chondrogenesis. The information gained may then be used for applications such as developing strategies for manipulating marrow mesenchymal cells to facilitate cartilage repair. The system may also be used for examining the effects of human genetic mutations in molecules that play a role in chondrogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044390-04
Application #
6124152
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Tyree, Bernadette
Project Start
1996-12-15
Project End
2000-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
4
Fiscal Year
2000
Total Cost
$170,127
Indirect Cost
Name
Case Western Reserve University
Department
Orthopedics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Markway, Brandon D; Cho, Holly; Zilberman-Rudenko, Jevgenia et al. (2015) Hypoxia-inducible factor 3-alpha expression is associated with the stable chondrocyte phenotype. J Orthop Res 33:1561-70
McAlinden, Audrey; Johnstone, Brian; Kollar, John et al. (2008) Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation. Matrix Biol 27:254-66
Sun, Yulong; Berger, Evelyn J; Zhao, Chunfeng et al. (2006) Expression and mapping of lubricin in canine flexor tendon. J Orthop Res 24:1861-8
Huang, Jerry I; Kazmi, Najam; Durbhakula, Mahidhar M et al. (2005) Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23:1383-9
Hering, Thomas M; Kazmi, Najam H; Huynh, Tru D et al. (2004) Characterization and chondrocyte differentiation stage-specific expression of KRAB zinc-finger protein gene ZNF470. Exp Cell Res 299:137-47
Hanada, K; Solchaga, L A; Caplan, A I et al. (2001) BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 81:284-94
Angele, P; Kujat, R; Nerlich, M et al. (1999) Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng 5:545-54
Johnstone, B; Hering, T M; Caplan, A I et al. (1998) In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-72
Yoo, J U; Barthel, T S; Nishimura, K et al. (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-57